FindTrial
Sign In

Optimal timing of Percutaneous coronary intervention in elderly acute ST-segment elevation myocardial infarction patients

Analysis of death related factors during hospitalization in STEMI patients undergoing emergency coronary intervention therapy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300072737
Enrollment
Unknown
Registered
2023-06-25
Start date
2023-06-12
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute myocardial infarction

Interventions

<24h:PCI < 24 hours after admission
24 to 72 hours:PCI during 24-72h
72 to 168 hours:PCI during 72-168h

Sponsors

Affiliated Hospital of Hebei University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Patients were included if they met at least 2 of the following criteria for STEMI (characteristic severe chest pain lasting =30 minutes, electrocardiographic changes or elevation of cardiac serum biomarkers) and if they experienced continuous ongoing symptoms or signs of ischemia (persistent/recurrent symptoms of myocardial ischemia or persistent ST-segment elevation/re-elevation on electrocardiography).

Exclusion criteria

Exclusion criteria: (1) younger than 60 years of age; (2) previous fibrinolytic treatment; or (3) lack of informed consent; or (4) treatment at a facility incapable of coronary angiography, angioplasty or stenting or (5) hemodynamic instability requiring emergency revascularization.

Design outcomes

Primary

MeasureTime frame
12-month cardiac mortality;nonfatal myocardial infarction; target-vessel revascularization;heart failure-related rehospitalization;—

Countries

China

Contacts

Public ContactHaiyan Jia

Affiliated Hospital of Hebei University

706550155@qq.com+86 181 3270 4520

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026